Connect with us


Recurrent GBM brain tumors with few mutations respond best to immunotherapy – Duke Department of Neurology

Glioblastoma brain tumors are especially perplexing.




Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after theyve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Dukes Preston Robert Tisch Brain Tumor Center, including the Neurology Department’s Katherine Peters, MD, PhD, Dina Randazzo,…

Click here to view the original article.

Continue Reading

You might also like ...

post featured image
Children of depressed mothers may experience suicidal thoughts: Study – Hindustan Times
post featured image
NHS boss says new COVID treatments in second half of 2021 offer hope of ‘much more normal future’ – Yahoo News Australia